These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 166332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of Parkinson's disease with lergotrile mesylate.
    Lieberman A, Estey E, Kupersmith M, Gopinathan G, Goldstein M.
    JAMA; 1977 Nov 28; 238(22):2380-2. PubMed ID: 335094
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate.
    Sherman BM, Swanson JA, Chapler FK.
    Fertil Steril; 1978 Mar 28; 29(3):291-5. PubMed ID: 565303
    [Abstract] [Full Text] [Related]

  • 9. Paradoxial response to dopaminergic agents in parkinsonism.
    Wiener WJ, Kramer J, Nausieda PA, Klawans HL.
    Arch Neurol; 1978 Jul 28; 35(7):453-5. PubMed ID: 666596
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.
    Clemens JA, Smalstig EB, Shaar CJ.
    Acta Endocrinol (Copenh); 1975 Jun 28; 79(2):230-7. PubMed ID: 166535
    [Abstract] [Full Text] [Related]

  • 11. The effect of lergotrile on galactorrhea and gonadotropin secretion.
    Cleary RE, Crabtree R, Lemberger L.
    J Clin Endocrinol Metab; 1975 May 28; 40(5):830-3. PubMed ID: 165221
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF, Rosin AJ, Plotkin CN, Calne DB.
    Br J Clin Pharmacol; 1980 Jan 28; 9(1):47-50. PubMed ID: 6101955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R, Shoulson I, Calne DB.
    Neurology; 1976 Jun 28; 26(6 PT 1):511-3. PubMed ID: 778655
    [Abstract] [Full Text] [Related]

  • 20. Bromocriptine, lergotrile: the antiparkinsonian efficacy and the interaction with monoaminergic receptors.
    Goldstein M, Lieberman A, Battista AF, Lew JY, Hata F.
    Pharmacology; 1978 Jun 28; 16 Suppl 1():143-9. PubMed ID: 25445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.